M&A TRANSACTION · 2021
Resurgens Orthopedics acquired by Welsh, Carson, Anderson & Stowe
$325.0M· 13.0x EBITDA
Target
Resurgens Orthopedics
Acquirer
Welsh, Carson, Anderson & Stowe
Private Equity buyer
Disclosed financials at time of acquisition
Revenue
—
EBITDA
$25.0M
Deal Value
$325.0M
EV/EBITDA
13.0x
Context
This $325.0M acquisition of Resurgens Orthopedics by Welsh, Carson, Anderson & Stowe sits in the medical practice specialty sub-vertical. The 13.0x EBITDA multiple paid in 2021 can be compared against the population median for medical practice specialty transactions of similar size on our Medical Practice Specialty valuation hub. Welsh, Carson, Anderson & Stowe is acquiring as a private equity buyer; see how PE acquirers typically price medical practice specialty businesses on our Medical Practice Specialty PE buyer-pool page.
Source
Data sourced from Press releases and press reporting. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical practice specialty
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the Resurgens Orthopedics acquisition.